Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study.

Sigmon SC, Dunn KE, Badger GJ, Heil SH, Higgins ST.

Addict Behav. 2009 Mar;34(3):304-11. doi: 10.1016/j.addbeh.2008.11.017. Epub 2008 Nov 24.

2.

Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.

Mannelli P, Peindl KS, Lee T, Bhatia KS, Wu LT.

Curr Drug Abuse Rev. 2012 Mar;5(1):52-63. Review.

3.

The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review.

Dunn KE, Sigmon SC, Strain EC, Heil SH, Higgins ST.

Drug Alcohol Depend. 2011 Dec 1;119(1-2):1-9. doi: 10.1016/j.drugalcdep.2011.05.033. Epub 2011 Jul 8. Review.

4.

Maintenance medication for opiate addiction: the foundation of recovery.

Bart G.

J Addict Dis. 2012;31(3):207-25. doi: 10.1080/10550887.2012.694598. Review.

5.

Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.

Sigmon SC, Bisaga A, Nunes EV, O'Connor PG, Kosten T, Woody G.

Am J Drug Alcohol Abuse. 2012 May;38(3):187-99. doi: 10.3109/00952990.2011.653426. Epub 2012 Mar 12. Review.

6.

Detoxification treatments for opiate dependent adolescents.

Minozzi S, Amato L, Bellisario C, Davoli M.

Cochrane Database Syst Rev. 2014 Apr 29;(4):CD006749. doi: 10.1002/14651858.CD006749.pub3. Review.

PMID:
24777492
7.

[Pharmacological treatment of substance dependence from a neuroscientific perspective (I): opiates and cocaine].

Haro G, Cervera G, Martínez-Raga J, Pérez-Gálvez B, Fernández-Garcés M, Sanjuan J.

Actas Esp Psiquiatr. 2003 Jul-Aug;31(4):205-19. Review. Spanish.

PMID:
12838444
8.

Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine.

Mendelson J, Flower K, Pletcher MJ, Galloway GP.

Exp Clin Psychopharmacol. 2008 Oct;16(5):435-41. doi: 10.1037/a0013637. Review.

9.

Opioid dependence treatment: options in pharmacotherapy.

Stotts AL, Dodrill CL, Kosten TR.

Expert Opin Pharmacother. 2009 Aug;10(11):1727-40. doi: 10.1517/14656560903037168. Review.

10.

Bupreorphine:a new pharmacotherapy for opioid addictions treatment.

Stock C, Shum JH.

J Pain Palliat Care Pharmacother. 2004;18(3):35-54. Review.

PMID:
15364630
11.

Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders.

McCann DJ.

Clin Pharmacol Ther. 2008 Apr;83(4):627-30. doi: 10.1038/sj.clpt.6100503. Epub 2008 Jan 23. Review.

PMID:
18212797
12.

Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.

Connery HS.

Harv Rev Psychiatry. 2015 Mar-Apr;23(2):63-75. doi: 10.1097/HRP.0000000000000075. Review.

PMID:
25747920
13.

Rapid and ultrarapid opioid detoxification techniques.

O'Connor PG, Kosten TR.

JAMA. 1998 Jan 21;279(3):229-34. Review.

PMID:
9438745
14.

Prescription pain medication dependence.

Dodrill CL, Helmer DA, Kosten TR.

Am J Psychiatry. 2011 May;168(5):466-71. doi: 10.1176/appi.ajp.2010.10020260. Review. No abstract available.

PMID:
21536702

Supplemental Content

Support Center